SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001126234-21-000079
Filing Date
2021-05-24
Accepted
2021-05-24 18:35:54
Documents
1
Period of Report
2021-05-20

Document Format Files

Seq Description Document Type Size
1 FORM 4 wf-form4_162189573692141.html 4  
1 FORM 4 wf-form4_162189573692141.xml 4 6613
  Complete submission text file 0001126234-21-000079.txt   8104
Mailing Address 4200 MARATHON BLVD. SUITE 200 AUSTIN TX 78756
Business Address 4200 MARATHON BLVD. SUITE 200 AUSTIN TX 78756 512-215-2630
LUMOS PHARMA, INC. (Issuer) CIK: 0001126234 (see all company filings)

IRS No.: 421491350 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O NEWLINK GENETICS CORPORATION 2503 SOUTH LOOP DRIVE AMES IA 50010
Business Address
JOHNSON CHAD ALLEN (Reporting) CIK: 0001734108 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-35342 | Film No.: 21956767